Skip to main content
BCDA
NASDAQ Life Sciences

FDA Says Ongoing CardiAMP HF II Trial May Support Approval

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.096
Mkt Cap
$16.047M
52W Low
$0.75
52W High
$1.8
52W Position info
46% above low
Off High info
39% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

BCDA sits 46% above its 52-week low of $0.75 on light trading volume (0.4× avg).

Summary

BioCardia announced that the FDA has agreed the ongoing CardiAMP HF II trial may be sufficient to support approval of its autologous cell therapy for heart failure. This is a meaningful regulatory de-risking event for a company with a market cap around $16 million. The trial is active, and the company will present a poster at HFSA 2026 (Oct 9-12), which may increase visibility. The news follows a series of regulatory milestones, including the Helix De Novo pre-submission and Nasdaq compliance regained. The key remaining question is whether the trial data will be positive enough to support an actual filing.

At the time of this announcement, BCDA was trading at $1.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16M. The 52-week trading range was $0.75 to $1.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BCDA - Latest Insights

BCDA
Aug 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.980
Real-time Price: $0.8811 info
Change: -$0.0989 (-10%) info
Market Cap: $13.339M info
BCDA
Aug 21, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.01
Real-time Price: $0.8811 info
Change: -$0.1289 (-13%) info
Market Cap: $13.339M info
BCDA
Aug 12, 2026, 4:27 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.902
Real-time Price: $0.8811 info
Change: -$0.0209 (-2%) info
Market Cap: $13.339M info
BCDA
Aug 12, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.870
Real-time Price: $0.8811 info
Change: +$0.0111 (+1%) info
Market Cap: $13.339M info
BCDA
Jun 24, 2026, 6:16 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.07
Real-time Price: $0.8811 info
Change: -$0.1889 (-18%) info
Market Cap: $13.339M info